VCM
CDNA icon

Versant Capital Management’s CareDx CDNA Stock Holding History

Versant Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3K Hold
958
– – ﹤0.01% 1764
2026
Q1 		$16.6K Buy
958
+87
+10% +$1.65K ﹤0.01% 1902
2025
Q4 		$16.4K Hold
871
– – ﹤0.01% 1754
2025
Q3 		$12.7K Buy
871
+776
+817% +$11.1K ﹤0.01% 1830
2025
Q2 		$1.86K Buy
+95
New +$1.69K ﹤0.01% 2397

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Versant Capital Management's CDNA Position: Q2 2026 in Review

Versant Capital Management held its CareDx (CDNA) position steady in Q2 2026 at 958 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Versant Capital Management first reported a position in CDNA in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Versant Capital Management held 958 shares of CareDx worth $27.3K as of Q2 2026.
  • Versant Capital Management left its CareDx share count unchanged in Q2 2026.
  • CareDx made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1764 holding.
  • Versant Capital Management first reported a position in CareDx in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.